Literature DB >> 11735415

Role of the disulfide cleavage induced molten globule state of type a botulinum neurotoxin in its endopeptidase activity.

S Cai1, B R Singh.   

Abstract

Botulinum neurotoxins are produced by anaerobic Clostridium botulinum in an inactive form. The endopeptidase activity of type A botulinum neurotoxin (BoNT/A) is triggered by reduction of its disulfide bond between its heavy chain and light chain. By using circular dichroism spectroscopy, we show that, upon reduction of BoNT/A and under physiological temperature (37 degrees C), the BoNT/A loses most of its native tertiary structure, while retaining most of its secondary structure. This type of structure is characterized as a molten globule type conformation, which was further confirmed for BoNT/A by the characteristic binding of 1-anilinonaphthalene-8-sulfonic acid. Under nonreducing conditions where the interchain disulfide bond is intact, the enzymatically inactive BoNT/A did not show a molten globule type of structure. A temperature profile of the structure and enzyme activity of BoNT/A revealed that, under reducing conditions, there was a strong correlation in the existence of the molten globule structure and optimum endopeptidase activity at about 37 degrees C.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735415     DOI: 10.1021/bi011350g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Molecular basis of activation of endopeptidase activity of botulinum neurotoxin type E.

Authors:  Roshan V Kukreja; Shashi K Sharma; Bal Ram Singh
Journal:  Biochemistry       Date:  2010-03-23       Impact factor: 3.162

Review 2.  Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting.

Authors:  B R Singh
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

3.  Botulinum neurotoxin light chain refolds at endosomal pH for its translocation.

Authors:  Shuowei Cai; Roshan Kukreja; Sue Shoesmith; Tzuu-Wang Chang; Bal Ram Singh
Journal:  Protein J       Date:  2006-12       Impact factor: 2.371

4.  High Yield Preparation of Functionally Active Catalytic-Translocation Domain Module of Botulinum Neurotoxin Type A That Exhibits Uniquely Different Enzyme Kinetics.

Authors:  Harkiranpreet Kaur Dhaliwal; Nagarajan Thiruvanakarasu; Raj Kumar; Kruti Patel; Ghuncha Ambrin; Shouwei Cai; Bal Ram Singh
Journal:  Protein J       Date:  2017-12       Impact factor: 2.371

5.  Light chain separated from the rest of the type a botulinum neurotoxin molecule is the most catalytically active form.

Authors:  Nizamettin Gul; Leonard A Smith; S Ashraf Ahmed
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

6.  Cloning, expression, purification, and characterization of biologically active recombinant hemagglutinin-33, type A botulinum neurotoxin associated protein.

Authors:  Yu Zhou; Sowmya Paturi; Paul Lindo; Suzanne M Shoesmith; Bal Ram Singh
Journal:  Protein J       Date:  2007-01       Impact factor: 4.000

7.  Probing BoNT/A protease exosites: implications for inhibitor design and light chain longevity.

Authors:  Song Xue; Sacha Javor; Mark S Hixon; Kim D Janda
Journal:  Biochemistry       Date:  2014-10-21       Impact factor: 3.162

8.  Defining the nature of thermal intermediate in 3 state folding proteins: apoflavodoxin, a study case.

Authors:  Rebeca García-Fandiño; Pau Bernadó; Sara Ayuso-Tejedor; Javier Sancho; Modesto Orozco
Journal:  PLoS Comput Biol       Date:  2012-08-23       Impact factor: 4.475

9.  Attomolar detection of botulinum toxin type A in complex biological matrices.

Authors:  Karine Bagramyan; Jason R Barash; Stephen S Arnon; Markus Kalkum
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

10.  A novel role of C-terminus in introducing a functionally flexible structure critical for the biological activity of botulinum neurotoxin.

Authors:  Thomas M Feltrup; Kruti Patel; Raj Kumar; Shuowei Cai; Bal Ram Singh
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.